+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

AtriCure Inc (ATRC) - Product Pipeline Analysis, 2020 Update

  • ID: 4239745
  • Company Profile
  • July 2020
  • 39 pages
  • GlobalData

FEATURED COMPANIES

  • Biosense Webster Inc
  • Boston Scientific Corp
  • DFine Inc
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

AtriCure Inc (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company develops, manufacture and sale of cardiac surgical ablation devices. Its major products include Isolator Synergy ablation system, a bipolar ablation clamp system; radio frequency ablation devices; cryoICE cryoablation system and AtriClip left atrial appendage (LAA) exclusion system. It also offers Lumitip dissectors and reusable cardiac surgery instruments. The company markets and sells its products in markets outside the US through its European subsidiaries and independent distributors. It has distributors in Asia Pacific, North America, South America, Europe, the Middle East, and Africa. AtriCure is headquartered in Mason, Ohio, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AtriCure Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosense Webster Inc
  • Boston Scientific Corp
  • DFine Inc
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
AtriCure Inc Company Overview
  • AtriCure Inc Company Snapshot
  • AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AtriCure Inc - Pipeline Analysis Overview
  • Business Description
  • AtriCure Inc - Key Facts
  • AtriCure Inc - Major Products and Services
  • AtriCure Inc Pipeline Products by Development Stage
  • AtriCure Inc Ongoing Clinical Trials by Trial Status
  • AtriCure Inc Pipeline Products Overview
  • AtriClip System - Stroke
  • AtriClip System - Stroke Product Overview
  • AtriClip System - Stroke Clinical Trial
  • AtriCure Bipolar System
  • AtriCure Bipolar System Product Overview
  • AtriCure Bipolar System Clinical Trial
  • cryoICE Ablation System - Atrial Fibrillation
  • cryoICE Ablation System - Atrial Fibrillation Product Overview
  • cryoICE Ablation System - Atrial Fibrillation Clinical Trial
  • Eclipse Surgical Left Atrial Appendage Closure Device
  • Eclipse Surgical Left Atrial Appendage Closure Device Product Overview
  • Isolator Synergy Encompass Clamp
  • Isolator Synergy Encompass Clamp Product Overview
  • LARIAT Suture Delivery Device - Adjunctive Therapy
  • LARIAT Suture Delivery Device - Adjunctive Therapy Product Overview
  • LARIAT Suture Delivery Device - Adjunctive Therapy Clinical Trial
  • Next Generation RF Generator
  • Next Generation RF Generator Product Overview
  • AtriCure Inc - Key Competitors
  • AtriCure Inc - Key Employees
  • AtriCure Inc - Key Employee Biographies
  • AtriCure Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • AtriCure Inc, Recent Developments
  • Jan 07, 2020: AtriCure announces successful completion of patient enrollment of aMAZE clinical trial and FDA approval of continued access protocol
  • Dec 04, 2019: AtriCure names two industry veterans to Board of Directors
  • Oct 30, 2019: AtriCure reports third quarter 2019 financial results
  • Aug 27, 2019: AtriCure receives clearance for expanded labeling claims for AtriClip devices
  • Jul 30, 2019: AtriCure reports second quarter 2019 Financial Results
  • Jul 30, 2019: SentreHEART announces initial clinical use of the LARIAT with EpiRAIL Procedure for left atrial appendage exclusion
  • May 06, 2019: SentreHEART announces participation and scheduled presentations at Heart Rhythm 2019
  • May 03, 2019: SentreHEART receives CE mark for LARIAT-RS 50mm and expanded indication for left atrial appendage exclusion
  • Apr 25, 2019: AtriCure reports first quarter 2019 financial results
  • Apr 23, 2019: AtriCure announces first patient enrollment in the DEEP IDE trial restart
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
  • AtriCure Inc Pipeline Products by Equipment Type
  • AtriCure Inc Pipeline Products by Indication
  • AtriCure Inc Ongoing Clinical Trials by Trial Status
  • AtriCure Inc, Key Facts
  • AtriCure Inc, Major Products and Services
  • AtriCure Inc Number of Pipeline Products by Development Stage
  • AtriCure Inc Pipeline Products Summary by Development Stage
  • AtriCure Inc Ongoing Clinical Trials by Trial Status
  • AtriCure Inc Ongoing Clinical Trials Summary
  • AtriClip System - Stroke - Product Status
  • AtriClip System - Stroke - Product Description
  • AtriClip System - Stroke - Stand-alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion with AtriClip Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation - the Polish Nationwide Registry
  • AtriCure Bipolar System - Product Status
  • AtriCure Bipolar System - Product Description
  • AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
  • cryoICE Ablation System - Atrial Fibrillation - Product Status
  • cryoICE Ablation System - Atrial Fibrillation - Product Description
  • cryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
  • Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
  • Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
  • Isolator Synergy Encompass Clamp - Product Status
  • Isolator Synergy Encompass Clamp - Product Description
  • LARIAT Suture Delivery Device - Adjunctive Therapy - Product Status
  • LARIAT Suture Delivery Device - Adjunctive Therapy - Product Description
  • LARIAT Suture Delivery Device - Adjunctive Therapy - Left Atrial Appendage Ligation with the LARIAT Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation
  • LARIAT Suture Delivery Device - Adjunctive Therapy - Non-randomized, Multicenter Expanded Use Evaluation of the LARIAT Suture Delivery Device (Appendix 16 to Ongoing Investigation)
  • Next Generation RF Generator - Product Status
  • Next Generation RF Generator - Product Description
  • AtriCure Inc, Key Employees
  • AtriCure Inc, Key Employee Biographies
  • AtriCure Inc, Other Locations
  • AtriCure Inc, Subsidiaries
  • Glossary
List of Figures
  • AtriCure Inc Pipeline Products by Equipment Type
  • AtriCure Inc Pipeline Products by Development Stage
  • AtriCure Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • St. Jude Medical LLC
  • Medtronic Plc
  • DFine Inc
  • Boston Scientific Corp
  • Biosense Webster Inc
Note: Product cover images may vary from those shown
Adroll
adroll